학술논문
Real-World Data on Subsequent Therapy for First-Line Osimertinib-Induced Pneumonitis: Safety of EGFR-TKI Rechallenge (Osi-risk Study TORG-TG2101)
Document Type
Article
Author
Nishioka, N.; Endo, M.; Doshita, K.; Hirai, S.; Yamamoto, C.; Imai, H.; Notsu, A.; Igawa, S.; Nakahara, Y.; Yokouchi, H.; Ninomiya, T.; Tokito, T.; Soda, S.; Fujiwara, T.; Asao, T.; Nakamichi, S.; Kawamura, T.; Inomata, M.; Nakashima, K.; Ito, K.; Goto, Y.; Umeda, Y.; Ushio, R.; Yokoo, K.; Takeda, T.; Fukui, T.; Ishihara, M.; Osaki, T.; Kubo, S.; Fujiwara, T.; Tsuda, T.; Tamura, N.; Hosokawa, S.; Chihara, Y.; Ikeda, S.; Furuya, N.; Miura, S.; Okamoto, H.
Source
In: Targeted Oncology . (Targeted Oncology, May 2024, 19(3):423-433)
Subject
Language
English
ISSN
1776260X
17762596
17762596